← Back
Data updated: Mar 10, 2026
SENTISS PHARMA
CardiovascularNeurology
SENTISS PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology.
2023
Since
1
Drugs
-
Trials
10
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TIMOLOL MALEATE 2025-05-20
Labeling
TIMOLOL MALEATE 2025-05-20
Labeling
TIMOLOL MALEATE 2025-05-19
Labeling
TIMOLOL MALEATE 2025-05-16
Manufacturing (CMC)
TIMOLOL MALEATE 2024-09-16
TIMOLOL MALEATE 2024-08-07
TIMOLOL MALEATE 2024-07-03
TIMOLOL MALEATE 2024-07-03
TIMOLOL MALEATE 2024-05-28
Labeling
TIMOLOL MALEATE 2024-05-23
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Neurology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-05-08
- Latest
- 2023-05-08
- Applications
- 1